Go offline with the Player FM app!
A Biotech Breakthrough?
Manage episode 244861425 series 8365
Biogen rises on news that it plans to file for FDA approval of its Alzheimers drug, Aducanumab. Under Armour gets a new CEO. And Hasbro tumbles on tariff trouble. Motley Fool analysts Andy Cross and Ron Gross tackle those stories and weigh in on the relative merits of Monopoly and Mr. Potato Head.
Thanks to Molekule for supporting our channel. Get 10% off your first air purifier at http://www.molekule.com with code fool10.
2032 episodes
Manage episode 244861425 series 8365
Biogen rises on news that it plans to file for FDA approval of its Alzheimers drug, Aducanumab. Under Armour gets a new CEO. And Hasbro tumbles on tariff trouble. Motley Fool analysts Andy Cross and Ron Gross tackle those stories and weigh in on the relative merits of Monopoly and Mr. Potato Head.
Thanks to Molekule for supporting our channel. Get 10% off your first air purifier at http://www.molekule.com with code fool10.
2032 episodes
Усі епізоди
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.